It's not evidence free. One of the things single payer does is negotiate discounts based on their whole country's population. That's going to fund ops and a bit of profit, not R&D.

> If they're so reliant on excess profits to fund R&D

R&D money comes from profits. It's not specific to the pharma industry. They just have particularly enormous R&D costs.